Strides Pharma Science Market Cap

Strides Pharma Science has a market cap or net worth of 62.77 billion as of April 24, 2025. Its market cap has decreased by -17.42% in one year.

Market Cap

62.77B

Enterprise Value

82.82B

Revenue

45.79B

Ranking

n/a

PE Ratio

18.29

Stock Price

682.80

Market Cap Chart

Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 62.77B, an increase of 737.57%. That is a compound annual growth rate of 8.79%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	61.36B	0.97%
Dec 31, 2024	60.77B	1.87%
Dec 29, 2023	59.66B	88.83%
Dec 30, 2022	31.59B	-21.29%
Dec 31, 2021	40.14B	-49.01%
Dec 31, 2020	78.72B	142.85%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,291.93B
Divi's Laboratories	1,572.77B
Cipla	1,238.64B
Mankind Pharma	1,072.37B
Apollo Hospitals Enterprise	1,026.91B
Zydus Lifesciences	873.41B
Aurobindo Pharma	724.14B
Alkem Laboratories	625.68B

Market Cap Rankings